Clinical trial
Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance
NCT00319189 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance
- Lead sponsor
- University of Oslo School of Pharmacy
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2002
- Completion date
- November 30, 2003
- Enrollment
- 15
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
posttransplant diabetes mellitus, posttransplant impaired glucose tolerance, renal transplant recipients